본문 바로가기

Effectiveness of Drug-Eluting Stents versus Bare-Metal Stents in Large Coronary Arteries in Patients with Acute Myocardial Infarction

문서 유형
연구출판물 · 학술지 논문
등재
KCISCIEScopus
저널 순위
JCR Q3
저널
JOURNAL OF KOREAN MEDICAL SCIENCE26(4) · pp.521 · 2011
피인용
Web of Science 21KCI 9
JCR IF
JCR 2010 0.834
ISSN
1011-8934

저자

  1. 심두선전남대학교
  2. 정명호전남대학교
  3. 안영근전남대학교
  4. 김영조영남대학교
  5. 채성철경북대학교
  6. 홍택종부산대학교
  7. 성인환충남대학교
  8. 채제건전북대학교
  9. 김종진경희대학교
  10. 조명찬충북대학교
  11. 승기배가톨릭대학교
  12. 박승정울산대학교
  13. 나승운고려대학교
  14. 오석규원광대학교
  15. 허승호계명대학교
  16. 조진만경희대학교
  17. 김수중경희대학교

초록

This study compared clinical outcomes of drug-eluting stents (DES) versus bare-metal stents (BMS) in large coronary arteries in patients with acute myocardial infarction (MI). A total of 985 patients who underwent single-vessel percutaneous coronary intervention (PCI) in large coronary arteries (>= 3.5 mm) in lesions < 25 mm were divided into DES group (n = 841) and BMS group (n = 144). Clinical outcomes during 12 months were compared. In-hospital outcome was similar between the groups. At six months, death/MI rate was not different. However, DES group had significantly lower rates of target-lesion revascularization (TLR) (1.7% vs 5.6%, P = 0.021), target-vessel revascularization (IVR) (2.2% vs 5.6%, P = 0.032), and total major adverse cardiac events (MACE) (3.4% vs 11.9%, P = 0.025). At 12 months, the rates of TLR and IVR remained lower in the DES group (2.5% vs 5.9%, P = 0.032 and 5.9% vs 3.1%, P = 0.041), but the rates of death/MI and total MACE were not statistically different. The use of DES in large vessels in the setting of acute MI is associated with lower need for repeat revascularization compared to BMS without compromising the overall safety over the course of one-year follow-up.

키워드

Myocardial InfarctionDrug-Eluting StentsTAXUS-IV TRIALRANDOMIZED-TRIALFOLLOW-UPUNCOATED STENTSVESSEL SIZERESTENOSISPREVENTIONDISEASEIMPLANTATIONMETAANALYSIS

식별자

WoS UID
000289534200008
KCI
ART001542955